Trial
NCT00476515
Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
Biogen; Genentech, Inc.
Condition
Kidney Insufficiency
Intervention
Rituximab
Why stopped
Protocol to be revised
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-23